Activated brown fat (aBAT) is known to affect the evaluation of 18F-FDG PET scans, especially in young patients. The aim of this study was to determine factors influencing the occurrence of aBAT, and to investigate the effectiveness of the two preventive measures, warming and beta-blocker (propranolol) administration. Five-hundred-twenty-eight 18F-FDG-PET scans of 241 EuroNet-PHL-C2 trial patients from 41 nuclear medicine departments in Germany and Czech Republic were screened for aBAT. The occurrence of aBAT was analyzed with patient characteristics (age, sex, body mass index, predisposition to aBAT), weather data at the day of 18F-FDG PET scanning as well as the preventive measures taken. Potentially important factors from univariate analyses were included into a logistic regression model. Warming as a preventive measure was used in 243 18F-FDG-PET scans, propranolol was administered in 36, warming and propranolol were combined in 84, and no preventive measures were taken in 165 scans. Whereas age, sex and body mass index had no clear impact, there was an individual predisposition to aBAT. Logistic regression model revealed that the frequency of aBAT mainly depends on the outside temperature (p = 0.005) and can be effectively reduced by warming (p = 0.004), the administration of unselective beta-blocker or the combination of both. Warming is a simple, cheap and non-invasive method to reduce the frequency of aBAT. However, the effect of warming decreases with increasing outside temperatures. Administration of propranolol seems to be equally effective and provides advantages whenever the positive effect of warming is compromised. The combination of both preventive measures could have an additive effect.

Department of Nuclear Medicine University Hospital of Leipzig University of Leipzig Liebigstraße 18 04103 Leipzig Germany

Department of Pediatric Hematology and Oncology Justus Liebig University Giessen Giessen Germany

Department of Pediatric Hematology and Oncology University Hospital Motol and 2nd Medical Faculty of Charles University Prague Czech Republic

Department of Radiology Medical Faculty of the Martin Luther University Halle Germany

Institute for Medical Informatics Statistics and Epidemiology University of Leipzig Leipzig Germany

Zobrazit více v PubMed

Vali R, Alessio A, Balza R, Borgwardt L, Bar-Sever Z, Czachowski M, Jehanno N, Kurch L, Pandit-Taskar N, Parisi M, Piccardo A, Seghers V, Skulkin BL, Zuchetta P, Lim R. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0. JNM. 2021;62(1):99–110. doi: 10.2967/jnumed.120.254110. PubMed DOI PMC

Drubach, L.A., Palmer, E.L., Connolly, L.P., Baker, A., Zurakowski, D., Cypress, A.M. Pediatric brown adipose tissue: Detection, epidemiology, and differences from adults. J. Pediatr. 939–944 (2011). PubMed

Merkel M, Schmid SM, Iwen KA. Physiologie und klinische Bedeutung von weißem, beigem und braunem Fettgewebe. Der Internist. 2019;60:115–121. doi: 10.1007/s00108-018-0540-0. PubMed DOI

Sacks H, Symonds ME. Anatomical locations of human brown adipose tissue—Functional relevance and implications in obesity and type 2 diabetes. Diabetes. 2013;62:1783–1790. doi: 10.2337/db12-1430. PubMed DOI PMC

Hao R, Yuan L, Zhang N, Li C, Yang J. Brown adipose tissue: Distribution and influencing factors on FDG PET/CT scan. J. Pediatr. Endocr. Met. 2012;25:233–237. PubMed

Steinberg JD, Vogel W, Vegt E. Factors influencing brown fat activation in FDG PET/CT: A retrospective analysis of 15,000+ cases. BJR. 2017 doi: 10.1259/bjr.201700093. PubMed DOI PMC

Izzi-Engbeaya C, Salem V, Atkar RS, Dhillo WS. Insight into brown adipose tissue physiology as revealed by imaging studies. Adipocyte. 2015 doi: 10.4161/21623945.2014.965609. PubMed DOI PMC

Kluge R, Kurch L, Georgi T, Metzger M. Current role of FDG-PET in Pediatric Hodgkin’s Lymphoma. Semin. Nucl. Med. 2017;47(3):242–257. doi: 10.1053/j.semnuclmed.2017.01.001. PubMed DOI

Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernádez-Teijeiro A, Fossa A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajic V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH. Response-adapated omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): A titration study with an open-label-embedded, multinational, non-inferiority, randomized controlled trial. Lancet Oncol. 2022;23:125–137. doi: 10.1016/S1470-2045(21)00470-8. PubMed DOI PMC

Mauz-Körholz C, Landman-Parker J, Fernández-Teijeriro A, Attarbaschi A, Balwierz W, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Ceppi F, Claviez A, Daw S, Dieckmann K, Fossa A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajic V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH. Response-adapated omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): A titration study. Lancet Oncol. 2023;24:252–261. doi: 10.1016/S1470-2045(23)00019-0. PubMed DOI

Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, DeLaat C, Fossati-Bellani F, Morgan E, Oberlin O, Reaman G, Ruymann FB, Tersak J, Meadows AT, on behalf of the Late Effects Study Group High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: Report from the Late Effects Study Group. JCO. 2003;21:4386–4394. doi: 10.1200/JCO.2003.11.059. PubMed DOI

Dörffel W, Riepenhausen M, Lüders H, Brämswig J, Schellong J. Secondary malignancies following treatment for Hodgkin’s lymphoma in childhood and adolescence—A cohort study with more than 30 years follow-up. Deutsches Ärzteblatt Int. 2015;112:320–327. PubMed PMC

Schellong G, Riepenhausen M, Bruch C, Kotthoff S, Vogt J, Bölling T, Dieckmann K, Pötter R, Heinecke A, Brämswig J, Dörffel W. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr. Blood Cancer. 2010;55:1145–1152. doi: 10.1002/pbc.22664. PubMed DOI

Morris B, Partap S, Yeom K, Gibbs IC, Fisher PG, King AA. Cerebrovascular disease in childhood cancer survivors: A Children’s Oncology Group Report. Neurology. 2009;73:1906–1913. doi: 10.1212/WNL.0b013e3181c17ea8. PubMed DOI PMC

https://www.skion.nl/workspace/uploads/EuroNet-PHL-C2_trial_protocol_final2-0-2015-07-27.pdf (27.04.2023)

Kurch L, Mauz-Körholz C, Bertling S, Wallinder M, Kaminska M, Marwede D, Tchavdarova L, Georgi TW, Elsner A, Barthel A, Stoevesandt D, Hasenclever D, Sattler B, Sabri O, Körholz D, Kluge R. The EuroNet paediatric Hodgkin network—Modern imaging data management for real time central review in multicentre trials. Klin. Padiatr. 2013;225:357–361. doi: 10.1055/s-0033-1354416. PubMed DOI

Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß HC, Hesse V, von Hippel A, Jaeger U, Johnsen D, Korte W, Menner K, Müller G, Müller JM, Niemann-Pilatus A, Remer R, Schaefer F, Wittchen H-U, Zabransky S, Zellner K, Ziegler A, Hebebrand J. Prezentile für den Body-mass-Index für das Kinder- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift Kinderheilkunde. 2001;149:807–818. doi: 10.1007/s001120170107. DOI

Brady SL, Wong KK, Doubrovin M, Han Y, Li Y, Wu S, Hossain AKMM, Chism CB, Naik MH, Rossi M, Shulkin BL. Effect of propranolol on 18F-fluorodeoxyglucose uptake in brown adipose tissue in children and young adults with neoplastic diseases. Mol. Imaging Biol. 2021;23:260–269. doi: 10.1007/s11307-020-01547-z. PubMed DOI PMC

Gilsanz V, Smith ML, Goodarzian F, Kim M, Wren TAL, Hu HH. Changes in brown adipose tissue in boys and girls during childhood and puberty. J. Pediatr. 2012;160:604–609. doi: 10.1016/j.jpeds.2011.09.035. PubMed DOI PMC

Gilsanz V, Chung SA, Jackson H, Dorey FJ, Hu HH. Functional brown adipose tissue is related to muscle volume in children and adolescents. J. Pediatr. 2011;158:722–726. doi: 10.1016/j.jpeds.2010.11.020. PubMed DOI PMC

Kaikaew K, Grefhorst A, Visser JA. Sex differences in brown adipose tissue function: Sex hormones, glucocorticoids, and their crosstalk. Front. Endocrinol. 2021 doi: 10.3389/fendo.2021.652444. PubMed DOI PMC

Cohade C, Mourtzikos KA, Wahl RL. “USA-Fat”: Prevalence is related to ambient outdoor temperature—Evaluation with 18F-FDG PET/CT. JNM. 2003;44:1267–1270. PubMed

Kim SH, Krynyckyi BR, Machac J, Kim CK. Temporal relation between temperature chance and FDG uptake in brown adipose tissue. Eur. J. Nucl. Med. Mol. Imaging. 2008;35:984–989. doi: 10.1007/s00259-007-0670-4. PubMed DOI

Zukotynski KA, Fahey FH, Laffin S, Davis R, Treves ST, Grant FD, Drubach LA. Constant ambient temperature of 24 °C significantly reduces FDG uptake by brown adipose tissue in children scanned during the winter. Eur. J. Nucl. Med. Mol. Imaging. 2009;36:602–606. doi: 10.1007/s00259-008-0983-y. PubMed DOI

https://www.usclimatedata.com/climate/cincinnati/ohio/united-states/usoh0188 (19.04.2023)

https://www.usclimatedata.com/climate/ann-arbor/michigan/united-states/usmi0028 (19.04.2023)

https://www.usclimatedata.com/climate/memphis/tennesse/united-states/ustn0325 (19.04.2023)

Söderlund V, Larsson SA, Jacobsson H. Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol. Eur. J. Nucl. Med. Mol. Imaging. 2007;34:1018–1022. doi: 10.1007/s00259-006-0318-9. PubMed DOI

Agrawal A, Nair N, Baghel NS. A novel approach for reduction of brown fat uptake on FDG PET. Br. J. Radiol. 2009;82:626–631. doi: 10.1259/bjr/24661539. PubMed DOI

Parysow O, Mollerach AM, Jager V, Racioppi S, Roman JS, Gerbaudo VH. Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin. Nucl. Med. 2007;32:351–357. doi: 10.1097/01.rlu.0000259570.69163.04. PubMed DOI

George A, Sinha P, Conrad G, Memon AA, Dressler EV, Wagner LM. Pilot study of propranolol premedication to reduce FDG uptake in brown adipose tissue on PET scans of adolescent and young adult oncology patients. Pediatr. Hematol. Oncol. 2017;34:149–156. doi: 10.1080/08880018.2017.1338806. PubMed DOI PMC